Chimera Investment (CIM) Stock Forecast, Price & News

Chimera Investment (NYSE:CIM) Frequently Asked Questions

Is Chimera Investment a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chimera Investment in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Chimera Investment stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CIM, but not buy additional shares or sell existing shares.
View analyst ratings for Chimera Investment or view top-rated stocks.

When is Chimera Investment's next earnings date?

Chimera Investment is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Chimera Investment.

How were Chimera Investment's earnings last quarter?

Chimera Investment Co. (NYSE:CIM) announced its quarterly earnings data on Thursday, May, 5th. The real estate investment trust reported $0.39 EPS for the quarter, topping the consensus estimate of $0.37 by $0.02. The real estate investment trust had revenue of $137.70 million for the quarter, compared to analysts' expectations of $141.03 million. Chimera Investment had a net margin of 27.85% and a trailing twelve-month return on equity of 14.02%. Chimera Investment's quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.36 EPS.
View Chimera Investment's earnings history.

How often does Chimera Investment pay dividends? What is the dividend yield for Chimera Investment?

Chimera Investment declared a quarterly dividend on Wednesday, May 4th. Shareholders of record on Thursday, June 30th will be given a dividend of $0.33 per share on Thursday, July 28th. This represents a $1.32 dividend on an annualized basis and a yield of 14.03%. The ex-dividend date of this dividend is Wednesday, June 29th.
View Chimera Investment's dividend history.

Is Chimera Investment a good dividend stock?

Chimera Investment pays an annual dividend of $1.32 per share and currently has a dividend yield of 14.27%. CIM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Chimera Investment does not yet have a strong track record of dividend growth. The dividend payout ratio of Chimera Investment is 185.92%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Chimera Investment will have a dividend payout ratio of 91.67% in the coming year. This indicates that Chimera Investment may not be able to sustain their current dividend.
View Chimera Investment's dividend history.

What price target have analysts set for CIM?

2 Wall Street analysts have issued 12 month target prices for Chimera Investment's shares. Their forecasts range from $11.00 to $11.00. On average, they anticipate Chimera Investment's share price to reach $11.00 in the next year. This suggests a possible upside of 16.9% from the stock's current price.
View analysts' price targets for Chimera Investment or view top-rated stocks among Wall Street analysts.

Who are Chimera Investment's key executives?

Chimera Investment's management team includes the following people:

• Mr. Mohit Marria, CEO, Chief Investment Officer & Director (Age 44, Pay $4.13M)
• Mr. Choudhary Yarlagadda, Pres, COO & Director (Age 60, Pay $4.81M)
• Mr. Phillip John Kardis II, Esq., Chief Legal Officer & Corp. Sec. (Age 61, Pay $4.1M)
• Mr. Subramaniam Viswanathan, Chief Financial Officer (Age 50)
• Mr. Kelley Kortman, Chief Accounting Officer (Age 51) (LinkedIn Profile)
• Ms. Emily Mohr, Investor Relations Officer
• Victor Falvo, Head of Capital Markets
• Mr. Dan Thakkar, Chief Risk Officer

What is Matthew Lambiase's approval rating as Chimera Investment's CEO?

3 employees have rated Chimera Investment CEO Matthew Lambiase on Glassdoor.com. Matthew Lambiase has an approval rating of 100% among Chimera Investment's employees. This puts Matthew Lambiase in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Chimera Investment's key competitors?

Some companies that are related to Chimera Investment include Annaly Capital Management (NLY), Starwood Property Trust (STWD), AGNC Investment (AGNC), Two Harbors Investment (TWO), Apollo Commercial Real Estate Finance (ARI), PennyMac Mortgage Investment Trust (PMT), MFA Financial (MFA), Ready Capital (RC), Redwood Trust (RWT), New York Mortgage Trust (NYMT), ARMOUR Residential REIT (ARR), Ares Commercial Real Estate (ACRE), Dynex Capital (DX), Invesco Mortgage Capital (IVR) and AG Mortgage Investment Trust (MITT).
View all of CIM's competitors.

What other stocks do shareholders of Chimera Investment own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chimera Investment investors own include New Residential Investment (NRZ), Annaly Capital Management (NLY), Marathon Oil (MRO), AGNC Investment (AGNC), Energy Transfer (ET), AT&T (T), ARMOUR Residential REIT (ARR), New York Mortgage Trust (NYMT), Enterprise Products Partners (EPD) and NGL Energy Partners (NGL).

What is Chimera Investment's stock symbol?

Chimera Investment trades on the New York Stock Exchange (NYSE) under the ticker symbol "CIM."

Who are Chimera Investment's major shareholders?

Chimera Investment's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.32%), BlackRock Inc. (8.06%), Thornburg Investment Management Inc. (7.27%), State Street Corp (2.30%), Leeward Investments LLC MA (1.15%) and Northern Trust Corp (1.01%).
View institutional ownership trends for Chimera Investment.

Which institutional investors are selling Chimera Investment stock?

CIM stock was sold by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Royal Bank of Canada, Mirae Asset Global Investments Co. Ltd., BlackRock Inc., Charles Schwab Investment Management Inc., Northern Trust Corp, First Trust Advisors LP, and Canada Pension Plan Investment Board.
View insider buying and selling activity for Chimera Investment or view top insider-selling stocks.

Which institutional investors are buying Chimera Investment stock?

CIM stock was purchased by a variety of institutional investors in the last quarter, including Leeward Investments LLC MA, Goldman Sachs Group Inc., Renaissance Technologies LLC, Allianz Asset Management GmbH, JPMorgan Chase & Co., State Street Corp, Federated Hermes Inc., and Sei Investments Co..
View insider buying and selling activity for Chimera Investment or or view top insider-buying stocks.

How do I buy shares of Chimera Investment?

Shares of CIM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chimera Investment's stock price today?

One share of CIM stock can currently be purchased for approximately $9.41.

How much money does Chimera Investment make?

Chimera Investment has a market capitalization of $2.23 billion and generates $937.55 million in revenue each year. The real estate investment trust earns $670.11 million in net income (profit) each year or $0.709990 on an earnings per share basis.

How many employees does Chimera Investment have?

Chimera Investment employs 38 workers across the globe.

What is Chimera Investment's official website?

The official website for Chimera Investment is www.chimerareit.com.

How can I contact Chimera Investment?

Chimera Investment's mailing address is 520 MADISON AVENUE 32ND FLOOR, NEW YORK NY, 10022. The real estate investment trust can be reached via phone at (212) 626-2300, via email at [email protected], or via fax at 212-696-9809.